STMM
NVO

South Texas Money Management’s Novo Nordisk NVO Stock Holding History

South Texas Money Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-873,830
Closed -$13.5M – 167
2013
Q2 		$13.5M Buy
+873,830
New +$14.5M 1.1% 41

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SF
Sarofim Fayez Houston, Texas $20.5B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

South Texas Money Management's NVO Position: Q3 2013 in Review

South Texas Money Management sold out of Novo Nordisk (NVO) in Q3 2013, closing a stake of 873,830 shares — an estimated $13.5M sold.

South Texas Money Management first reported a position in NVO in Q2 2013 and held it in 1 quarter. The position peaked at $13.5M in Q2 2013. 425 funds tracked by Wall St. Rank hold NVO as of Q3 2013.

  • South Texas Money Management reported no remaining Novo Nordisk position as of Q3 2013 after selling out during the quarter.
  • South Texas Money Management sold 873,830 Novo Nordisk shares in Q3 2013, an estimated $13.5M.
  • South Texas Money Management first reported a position in Novo Nordisk in Q2 2013 and held it in 1 quarter.
  • South Texas Money Management's Novo Nordisk position peaked at $13.5M in Q2 2013.
  • 425 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2013.

Based on South Texas Money Management's 13F filing for Q3 2013, filed 23 Oct 2013.